CTRI/2023/10/058245RecruitingPhase 2/3
A single blind randomized comparative clinical study to evaluate the efficacy of Eranda saptaka kwatha and Rasonadi kwatha in the management of Stabdhata and Ruja associated with Amavatha.
Dr Samprath Nayak1 site in 1 country60 target enrollmentStarted: October 10, 2023Last updated:
Trial Snapshot
- Phase
- Phase 2/3
- Status
- Recruiting
- Sponsor
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Pain
Study Overview
Brief Summary
This is a single blind randomized comparative clinical study to evaluate the effect of eranda saptaka kwatha and rasonadi kwatha for 30 days. This study comprise of two groups of 30 subjects with pain and stiffness associated with Amavata. Study will be conducted in ALN Rao memorial ayurvedic hospitals in koppa and quard hitlow places, koppa taluk, chikmagaluru distric 577126, karnataka, india. Primary out come measure will be Ruja(pain) and Stabdhata(stiffness) fin 30 days.
Study Design
- Study Type
- Interventional
- Allocation
- Permuted block randomization, fixed
- Masking
- Participant Blinded
Eligibility Criteria
- Ages
- 20.00 Year(s) to 60.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Patients of age group above 20 years and below 60 years
- •Patients diagnosed as Amavata on basis of Classical Lakshanas, specifically considering Stabdhata and Ruja for study.
- •Patient with controlled systemic diseases.
Exclusion Criteria
- •Patients below 20 years and above 60 years.
- •Other complicated joint disorders.
- •Complications including deformities, contractures and nodules.
Outcomes
Primary Outcomes
Pain
Time Frame: 30 days
stiffness
Time Frame: 30 days
Secondary Outcomes
- not applicable(not applicable)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Not yet recruiting
Not Applicable
A clinical trial to study the effect of changes in the strength of pulse to predict the onset of caudal block which is a method of giving pain relief in childrenCTRI/2021/06/034021Institute of Anaesthesiology and Critical care60
Completed
Phase 2
Efficacy and Safety of Enisamium Iodide for the Treatment of Acute Respiratory Viral Infections, Including Influenza.Acute Respiratory Viral InfectionsHuman InfluenzaNCT04682444Joint Stock Company "Farmak"100
Completed
Phase 3
An Efficacy and Safety Study of GNR-086 (Canakinumab Biosimilar) and Ilaris® in Patients With Adult-onset Still's DiseaseStill's Disease Adult OnsetNCT06497491AO GENERIUM118
Unknown
Phase 4
Comparison of Oral Versus Subcutaneous Route of Methotrexate Administration in Moderate to Severe PsoriasisPsoriasis VulgarisNCT03408756Post Graduate Institute of Medical Education and Research, Chandigarh100
Active, not recruiting
Phase 1
A Safety and Pharmacokinetics Study of Complarate (Tocilizumab Biosimilar Solution) and Actemra® in Healthy VolunteersHealthy VolunteersNCT06488521AO GENERIUM256